Home
/
Verastem, Inc.
/
Financials
/
Quarterly
Verastem, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Verastem, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$11.24M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$2.14M
Aug 7, 2025
Q3
2025
Sep 30, 2024
$10.00M
Nov 4, 2025
Q1
2024
Jun 30, 2024
$10.00M
Aug 8, 2024
Q2
2025
Jun 30, 2024
$10.00M
Aug 7, 2025
Q2
2018
Jun 30, 2018
$10.00M
Aug 8, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$10.00M
Nov 6, 2024
Q1
2024
Jun 30, 2024
$10.00M
Aug 8, 2024
Q3
2023
Sep 30, 2022
$2.60M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$2.60M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$2.60M
May 9, 2023
Q3
2022
Sep 30, 2021
$2.0K
Nov 3, 2022
Q2
2022
Jun 30, 2021
$500.0K
Aug 8, 2022
Q1
2022
Mar 31, 2021
$1.01M
May 9, 2022
Q3
2021
Sep 30, 2020
$78.65M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$4.31M
Aug 2, 2021
Q1
2021
Mar 31, 2020
$5.06M
May 11, 2021
Q3
2020
Sep 30, 2019
$9.03M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$3.14M
Aug 10, 2020
Q1
2020
Mar 31, 2019
$1.67M
May 7, 2020
Q3
2019
Sep 30, 2018
$15.51M
Oct 30, 2019
Q2
2019
Jun 30, 2018
$10.00M
Aug 1, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($98.52M)
Nov 4, 2025
Q3
2025
Jun 30, 2025
($25.93M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($25.93M)
Aug 7, 2025
Q3
2025
Mar 31, 2025
($52.10M)
Nov 4, 2025
Q1
2025
Mar 31, 2025
($52.10M)
May 13, 2025
Q2
2025
Mar 31, 2025
($52.10M)
Aug 7, 2025
Q3
2025
Sep 30, 2024
($23.97M)
Nov 4, 2025
Q1
2024
Jun 30, 2024
($8.26M)
Aug 8, 2024
Q2
2025
Jun 30, 2024
($8.26M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($8.26M)
Nov 4, 2025
Q3
2025
Mar 31, 2024
($33.86M)
Nov 4, 2025
Q1
2025
Mar 31, 2024
($33.86M)
May 13, 2025
Q2
2025
Mar 31, 2024
($33.86M)
Aug 7, 2025
Q3
2024
Sep 30, 2023
($20.00M)
Nov 6, 2024
Q2
2023
Jun 30, 2023
($24.28M)
Aug 8, 2023
Q3
2024
Jun 30, 2023
($24.28M)
Nov 6, 2024
Q1
2024
Jun 30, 2023
($24.28M)
Aug 8, 2024
Q2
2023
Mar 31, 2023
($15.71M)
Aug 8, 2023
Q1
2024
Mar 31, 2023
($15.71M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($15.71M)
Nov 6, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($40.72M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($43.76M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($44.17M)
May 13, 2025
Q3
2025
Sep 30, 2024
($37.03M)
Nov 4, 2025
Q1
2024
Jun 30, 2024
($18.28M)
Aug 8, 2024
Q2
2025
Jun 30, 2024
($18.28M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($28.06M)
May 13, 2025
Q3
2024
Sep 30, 2023
($21.31M)
Nov 6, 2024
Q1
2024
Jun 30, 2023
($20.29M)
Aug 8, 2024
Q2
2023
Jun 30, 2023
($20.29M)
Aug 8, 2023
Q1
2024
Mar 31, 2023
($19.34M)
May 9, 2024
Q3
2023
Sep 30, 2022
($17.71M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($21.40M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($16.98M)
May 9, 2023
Q3
2022
Sep 30, 2021
($14.85M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($15.94M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($14.11M)
May 9, 2022
Q3
2021
Sep 30, 2020
$15.02M
Nov 4, 2021
Q2
2021
Jun 30, 2020
($21.26M)
Aug 2, 2021
Q1
2021
Mar 31, 2020
($26.36M)
May 11, 2021